Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Sexually Transmitted Infection | Research

PrEP use and unmet PrEP-need among men who have sex with men in London prior to the implementation of a national PrEP programme, a cross-sectional study from June to August 2019

Authors: Dana Ogaz, Louise Logan, Tyrone J. Curtis, Lorraine McDonagh, Luis Guerra, Daniel Bradshaw, Poorvi Patel, Chiara Macri, Gary Murphy, O. Noel Gill, Anne M. Johnson, Anthony Nardone, Fiona Burns

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

Access to prevention options, including HIV pre-exposure prophylaxis (PrEP), remains a public health priority for gay, bisexual, and other men who have sex with men (MSM), especially in London. We describe PrEP use in a London community sample of MSM before the introduction of a national PrEP programme in October 2020.

Methods

From June–August 2019, MSM aged ≥ 18 recruited from London commercial venues were asked to self-complete a sexual health questionnaire and provide an oral fluid sample for anonymous HIV antibody testing. Descriptive analyses of demographic characteristics, service engagement and outcomes, as well as sexual risk and prevention behaviours were examined in the survey population and in those reporting current PrEP use. We performed sequential, multivariate analyses examining current PrEP use in MSM of self-perceived HIV-negative/unknown status with identified PrEP-need defined as the report of condomless anal sex (CAS) in the last three months, or the report of CAS (in the last year) with an HIV-positive/unknown status partner not known to be on HIV treatment, in reflection of UK PrEP guidelines.

Results

One thousand five hundred and thirty-fifth questionnaires were completed across 34 venues, where 1408 were analysed. One in five MSM of self-perceived HIV-negative/unknown status reported current PrEP use (19.7%, 242/1230). In men with PrEP-need, 68.2% (431/632) did not report current use. Current PrEP use was associated with age (aOR: 3.52, 95% CI: 1.76–7.02 in men aged 40–44 vs men aged 18–25) and education (aOR: 1.72, 95% CI: 1.01–2.92 in men with ≥ 2 years/still full-time vs no/ < 2 years of education since age 16).

Conclusion

Among MSM in London, PrEP use is high but there is indication of unmet PrEP-need in men of younger age and lower levels of post-16 education. National programme monitoring and evaluation will require continued community monitoring to guide interventions ensuring equitable PrEP access and uptake in those who could most benefit from PrEP.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mitchell H AH, Sonubi T, Kuyumdzhieva G, Harb A, Shah A, Glancy M, Checchi M,, Milbourn H FK, Mohammed H and contributors. Sexually transmitted infections and screening for chlamydia in England, 2019. Public Health England, London; 2020. Mitchell H AH, Sonubi T, Kuyumdzhieva G, Harb A, Shah A, Glancy M, Checchi M,, Milbourn H FK, Mohammed H and contributors. Sexually transmitted infections and screening for chlamydia in England, 2019. Public Health England, London; 2020.
3.
go back to reference Department for Health and Social Care. Towards Zero - An action plan towards ending HIV transmission, AIDS and HIV-related deaths in England - 2022 to 2025. 2021. Department for Health and Social Care. Towards Zero - An action plan towards ending HIV transmission, AIDS and HIV-related deaths in England - 2022 to 2025. 2021.
4.
go back to reference Brizzi F, Birrell PJ, Kirwan P, Ogaz D, Brown AE, Delpech VC, et al. Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study. Lancet HIV. 2021;8(7):e440–8.CrossRef Brizzi F, Birrell PJ, Kirwan P, Ogaz D, Brown AE, Delpech VC, et al. Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study. Lancet HIV. 2021;8(7):e440–8.CrossRef
5.
go back to reference McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London, England). 2016;387(10013):53–60.CrossRef McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London, England). 2016;387(10013):53–60.CrossRef
6.
go back to reference Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402–10.CrossRef Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402–10.CrossRef
7.
go back to reference Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629–37.CrossRef Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629–37.CrossRef
9.
go back to reference Mitchell HD, Desai S, Mohammed H, Ong KJ, Furegato M, Hall V, et al. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England. Sexually Trans Infect. 2019;95(7):484–7.CrossRef Mitchell HD, Desai S, Mohammed H, Ong KJ, Furegato M, Hall V, et al. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England. Sexually Trans Infect. 2019;95(7):484–7.CrossRef
12.
go back to reference Brady M, Rodger A, Asboe D, Cambiano V, Clutterbuck D, Desai M, et al. BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. HIV Med. 2019;20(Suppl 2):s2–80.PubMed Brady M, Rodger A, Asboe D, Cambiano V, Clutterbuck D, Desai M, et al. BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. HIV Med. 2019;20(Suppl 2):s2–80.PubMed
14.
go back to reference Saunders John, Gill O Noel, Delpech Valerie, Estcourt Claudia, the Five Nations (England, Scotland, Wales, Northern Ireland, Republic of Ireland) PrEP Minimum Dataset Working Group. Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019. Euro Surveill. 2021;26(23). https://doi.org/10.2807/1560-7917.ES.2021.26.23.2001595. Saunders John, Gill O Noel, Delpech Valerie, Estcourt Claudia, the Five Nations (England, Scotland, Wales, Northern Ireland, Republic of Ireland) PrEP Minimum Dataset Working Group. Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019. Euro Surveill. 2021;26(23). https://​doi.​org/​10.​2807/​1560-7917.​ES.​2021.​26.​23.​2001595.
15.
go back to reference Aghaizu A, Wayal S, Nardone A, Parsons V, Copas A, Mercey D, et al. Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000–13: a serial cross-sectional study. Lancet HIV. 2016;3(9):e431–40.CrossRef Aghaizu A, Wayal S, Nardone A, Parsons V, Copas A, Mercey D, et al. Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000–13: a serial cross-sectional study. Lancet HIV. 2016;3(9):e431–40.CrossRef
17.
go back to reference Clifton S, Nardone A, Field N, Mercer CH, Tanton C, Macdowall W, et al. HIV testing, risk perception, and behaviour in the British population. AIDS (London, England). 2016;30(6):943–52.CrossRef Clifton S, Nardone A, Field N, Mercer CH, Tanton C, Macdowall W, et al. HIV testing, risk perception, and behaviour in the British population. AIDS (London, England). 2016;30(6):943–52.CrossRef
18.
go back to reference Di Ciaccio M, Sagaon-Teyssier L, Protière C, Mimi M, Suzan-Monti M, Meyer L, et al. Impact of HIV risk perception on both pre-exposure prophylaxis and condom use. J Health Psychol. 2021;26(10):1575–86.CrossRef Di Ciaccio M, Sagaon-Teyssier L, Protière C, Mimi M, Suzan-Monti M, Meyer L, et al. Impact of HIV risk perception on both pre-exposure prophylaxis and condom use. J Health Psychol. 2021;26(10):1575–86.CrossRef
19.
go back to reference Witzel TC, Nutland W, Bourne A. What are the motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men aged 18–45 in London? Results from a qualitative study. Sexually Trans Infect. 2019;95(4):262–6.CrossRef Witzel TC, Nutland W, Bourne A. What are the motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men aged 18–45 in London? Results from a qualitative study. Sexually Trans Infect. 2019;95(4):262–6.CrossRef
20.
go back to reference Hanum N, Cambiano V, Sewell J, Phillips AN, Rodger AJ, Speakman A, et al. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public health. 2020;5(9):e501–11.CrossRef Hanum N, Cambiano V, Sewell J, Phillips AN, Rodger AJ, Speakman A, et al. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public health. 2020;5(9):e501–11.CrossRef
22.
go back to reference Annequin M, Villes V, Delabre RM, Alain T, Morel S, Michels D, et al. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017). AIDS Care. 2020;32(sup2):47–56.CrossRef Annequin M, Villes V, Delabre RM, Alain T, Morel S, Michels D, et al. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017). AIDS Care. 2020;32(sup2):47–56.CrossRef
23.
go back to reference Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. JAMA. 2019;321(14):1380–90.CrossRef Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. JAMA. 2019;321(14):1380–90.CrossRef
24.
go back to reference Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Lancet HIV. 2019;6(7):e447–55.CrossRef Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Lancet HIV. 2019;6(7):e447–55.CrossRef
25.
go back to reference Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart LE, et al. Changes in Sexual Behavior and STI Diagnoses Among MSM Initiating PrEP in a Clinic Setting. AIDS Behav. 2019;23(2):548–55.CrossRef Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart LE, et al. Changes in Sexual Behavior and STI Diagnoses Among MSM Initiating PrEP in a Clinic Setting. AIDS Behav. 2019;23(2):548–55.CrossRef
26.
go back to reference McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, et al. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men. JAMA Netw Open. 2020;3(12):e2030806.CrossRef McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, et al. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men. JAMA Netw Open. 2020;3(12):e2030806.CrossRef
27.
go back to reference Estcourt C, Yeung A, Nandwani R, Goldberg D, Cullen B, Steedman N, et al. Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM. AIDS (London, England). 2021;35(4):665–73.CrossRef Estcourt C, Yeung A, Nandwani R, Goldberg D, Cullen B, Steedman N, et al. Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM. AIDS (London, England). 2021;35(4):665–73.CrossRef
28.
go back to reference Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020;7(2):e113–20.CrossRef Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020;7(2):e113–20.CrossRef
29.
go back to reference Curlin ME, Gvetadze R, Leelawiwat W, Martin M, Rose C, Niska RW, et al. Analysis of false-negative human immunodeficiency virus rapid tests performed on oral fluid in 3 international clinical research studies. Clin Infect Dis. 2017;64(12):1663–9.CrossRef Curlin ME, Gvetadze R, Leelawiwat W, Martin M, Rose C, Niska RW, et al. Analysis of false-negative human immunodeficiency virus rapid tests performed on oral fluid in 3 international clinical research studies. Clin Infect Dis. 2017;64(12):1663–9.CrossRef
30.
go back to reference Elliott T, Sanders EJ, Doherty M, Ndung’u T, Cohen M, Patel P, et al. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review. J Int AIDS Soc. 2019;22(12):e25419-e.CrossRef Elliott T, Sanders EJ, Doherty M, Ndung’u T, Cohen M, Patel P, et al. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review. J Int AIDS Soc. 2019;22(12):e25419-e.CrossRef
31.
go back to reference Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, et al. The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion. AIDS (London, England). 2017;31(14):2007–16.CrossRef Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, et al. The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion. AIDS (London, England). 2017;31(14):2007–16.CrossRef
32.
go back to reference Tittle V, Boffito M, McOwan A, Whitlock G. Antiretroviral resistance and management after pre-exposure prophylaxis. The Lancet HIV. 2020;7(2):e84.CrossRef Tittle V, Boffito M, McOwan A, Whitlock G. Antiretroviral resistance and management after pre-exposure prophylaxis. The Lancet HIV. 2020;7(2):e84.CrossRef
33.
go back to reference Girometti N, McCormack S, Tittle V, McOwan A, Whitlock G. Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes. AIDS (London, England). 2022;36(4):561–6.CrossRef Girometti N, McCormack S, Tittle V, McOwan A, Whitlock G. Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes. AIDS (London, England). 2022;36(4):561–6.CrossRef
34.
go back to reference World Health Organization. HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis. Geneva: World Health Organization; 2020. World Health Organization. HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis. Geneva: World Health Organization; 2020.
35.
go back to reference O'Halloran C, Croxford S, Mohammed H, Gill ON, Hughes G, Fifer H, et al. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK. Sexually transmitted infections. 2020. O'Halloran C, Croxford S, Mohammed H, Gill ON, Hughes G, Fifer H, et al. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK. Sexually transmitted infections. 2020.
37.
go back to reference Arnold-Forster D, Horne R, Nutland W, Wayal S, Rayment M, Rae C, Desai M, Clarke A, Sullivan A, McCormack S, Gafos M. Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England. AIDS Behav. 2022. https://doi.org/10.1007/s10461-022-03624-6. Epub ahead of print. PMID: 35182281. Arnold-Forster D, Horne R, Nutland W, Wayal S, Rayment M, Rae C, Desai M, Clarke A, Sullivan A, McCormack S, Gafos M. Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England. AIDS Behav. 2022. https://​doi.​org/​10.​1007/​s10461-022-03624-6. Epub ahead of print. PMID: 35182281.
38.
go back to reference Savage EJ, Mohammed H, Leong G, Duffell S, Hughes G. Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: the genitourinary medicine clinic activity dataset, England, 2009 to 2013. Eurosurveillance. 2014;19(48):20981.CrossRef Savage EJ, Mohammed H, Leong G, Duffell S, Hughes G. Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: the genitourinary medicine clinic activity dataset, England, 2009 to 2013. Eurosurveillance. 2014;19(48):20981.CrossRef
Metadata
Title
PrEP use and unmet PrEP-need among men who have sex with men in London prior to the implementation of a national PrEP programme, a cross-sectional study from June to August 2019
Authors
Dana Ogaz
Louise Logan
Tyrone J. Curtis
Lorraine McDonagh
Luis Guerra
Daniel Bradshaw
Poorvi Patel
Chiara Macri
Gary Murphy
O. Noel Gill
Anne M. Johnson
Anthony Nardone
Fiona Burns
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-13425-0

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue